HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$15.29
Day range
$13.71 - $15.18
Year range
$5.88 - $30.40
Market cap
1.22B USD
Avg Volume
67.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 27.17M | -85.67% |
Operating expense | 18.12M | -86.06% |
Net income | 7.53M | -81.45% |
Net profit margin | 27.72 | 29.47% |
Earnings per share | — | — |
EBITDA | 8.35M | -84.73% |
Effective tax rate | 20.40% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 37.35M | -76.76% |
Total assets | 122.01M | -84.87% |
Total liabilities | 33.24M | -66.36% |
Total equity | 88.77M | — |
Shares outstanding | 85.42M | — |
Price to book | 23.17 | — |
Return on assets | 16.92% | — |
Return on capital | 24.03% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 7.53M | -81.45% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2002
Headquarters
Website
Employees
593